NSE filing, NSE: GRASIM. Summary written from the filing by ALFA Finder's alert engine.
Grasim Industries Ltd: key numbers
- Share price
- ₹3,115.00
- Market cap
- ₹2,11,982 Cr
- Revenue (annual)
- ₹1,75,431 Cr
- Net profit (annual)
- ₹4,966 Cr
- P/E (TTM)
- 37.2×Sector 32.4×
- Promoter holding
- 45.20%+1.46% QoQ
- FII holding
- 14.50%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Grasim Industries Ltd
All →Grasim Industries Regulatory Approval
CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.
Grasim Industries Board Meeting Date
Grasim Industries scheduled its Board meeting for 13 Nov 2026 to approve Q2 and H1 unaudited financial results. Trading window remains closed until 15 Nov 2026.
Grasim Industries Debt & Borrowing: ₹750 Cr
Grasim Industries repaid ₹750 Crore of Commercial Paper (ISIN INE047A14BE6) at maturity on 26 Oct 2026. Outstanding CP amount is now Nil.
- Value
- ₹750.0 Cr
Grasim Industries Legal & Regulatory
Grasim replied to exchange queries on a news item. The Bombay HC quashed the Rs 329 crore reassessment notice, with no demand or financial impact.
Grasim Industries Production Started
Grasim Industries has commenced commercial production at its Epichlorohydrin plant in Vilayat, Gujarat, with a capacity of 50 K TPA. This strengthens its downstream chlor-alkali derivatives portfolio.
- epichlorohydrin (ECH) manufacturing capacity
- 50000 TPA
Grasim Industries Other Announcement
Grasim Industries Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI listing regulations.
Other partnership announcements
All →Alembic Pharmaceuticals Partnership
Alembic Pharmaceuticals expanded its strategic collaboration with DifGen Pharmaceuticals to commercialize over 20 complex generic products in the US. The portfolio targets a US$5 billion market.
- From
- DifGen Pharmaceuticals
- Execution
- Initial launches from FY28
Kothari Industrial Corporation Partnership
Kothari Industrial Corporation signed a five-year MoU with The University of Western Australia. The collaboration spans education, research, mentorships and internships via the UWA Global Engagement Alliance.
- From
- The University of Western Australia (UWA), Australia
- Execution
- five years from the date of the last signature
Rose Merc Partnership
Rose Merc Ltd signed a Lead Marketing, Sales and Project Collaboration Agreement with CATS Eco Systems. No fixed contract value is specified, and no shares are issued.
- Execution
- Five years from November 3, 2026, subject to renewal or earlier termination
Emerald Finance Partnership
Emerald Finance appointed as a Direct Selling Agent by Unity Small Finance Bank to source Gold Loan business Pan India. The filing announces a new business association but states no monetary value.
- From
- Unity Small Finance Bank
Bondada Engineering Partnership
Bondada signed a non-binding MoU with Goa-IPB for proposed ₹3,000 Crore solar and biogas projects in Goa. The deal anticipates 700+ jobs, subject to approvals.
- Value
- ₹3,000 Cr
- From
- Goa Investment Promotion and Facilitation Board (Goa-IPB), Government of Goa
Belrise Industries Partnership
Belrise Industries has signed a licence and technical assistance agreement with Japan's Yamato Co. for filter products. It grants Indian manufacturing rights, with royalty and fees payable.